Replies to post #182243 on Biotech Values

[Biowatch]

Harlan replaces Sam Waksal as Kadmon's CEO

From CNBC
http://www.cnbc.com/id/102032718

Waksal brothers reunite in ImClone 2.0
Meg Tirrell
Thursday, 25 Sep 2014

...CNBC reported Wednesday that Sam Waksal will step aside as chief executive of closely held Kadmon as the company plans to file for an initial public offering. Because of Waksal's ban from serving as an officer of a public company that stemmed from his insider trading charges, his brother, Harlan, is joining the company as president and CEO.

Kadmon confirmed the news in a press release, also noting Sam Waksal would remain chairman, "and will transition from that role in the event that the company elects to pursue an initial public offering."

From the company PR:
http://kadmon.com/posts/view/118

NEW YORK, September 24, 2014 – Kadmon Corporation, LLC announces today that Harlan W. Waksal, M.D., has joined the Company as its President and Chief Executive Officer after serving as a member of the Company’s Board of Managers since April 2014. Dr. Harlan Waksal replaces Samuel D. Waksal, Ph.D., one of the founders of Kadmon, in the Chief Executive role. Dr. Samuel Waksal remains with the Company as Chief of Innovation, Science and Strategy...